Lv1
2 积分 2024-05-30 加入
15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center study
20天前
已完结
Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome
20天前
已完结
Moderate‐To‐Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts
20天前
已完结
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML : A Multicenter Study of the ECLA Group
20天前
已完结
Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial
24天前
已完结
Optimized PET/CT response assessment for prognostic stratification compared with Lugano criteria in extranodal NK/T-Cell lymphoma
24天前
已完结
Anti-CD19 antibody tafasitamab therapy for relapsed or refractory diffuse large B-cell lymphoma: a case series
24天前
已完结
A hybrid few-shot multiple-instance learning model predicting the aggressiveness of lymphoma in PET/CT images
30天前
已完结
18F-FDG PET-Based Combined Baseline and End-Of-Treatment Radiomics Model Improves the Prognosis Prediction in Diffuse Large B Cell Lymphoma After First-Line Therapy
30天前
已完结
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma
1个月前
已完结
皖公网安备34019202002308
